Imagine persistent chronic lower back pain, which is a wide range of pain that affects a large number of adults around the world. Often, s-bone joints are considered a key source of this pain, triggering an urgent need for effective treatment. Regular therapies often fail to provide adequate relief, prompting researchers to investigate advanced surgical options such as minimally invasive sacroiliac joint fusion. This technique is touted to greatly relieve pain, but does it really outperform a placebo?
New insights from a new study recently published in the February 2024 journal Eclinicalmedicine provide a detailed study on the effectiveness of minimally invasive Sacroiliac joint fusion and the effectiveness of sham or sham surgery. By Dr. Engelke Marie Randers, Dr. Britt Stuge, Professor Lars Nordsletten, Professor Stephan M. Röhrl and Dr. Thomas Kibsgård of the University of Oslo and Dr. Elias Diarbakerli of the Karolinska Institutet and Karo Dr. linska Institutet and Professor Paul Gerdhem of Professor Karolinska Institutet and Professor Karolinska Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterintka Insterthem’s Thomas Kibsgård guidance. and Uppsala University, the study provides a double-blind study of surgical methods for placebo procedures.
Dr. Landers shared insights on the importance of their findings and stressed: “Our trial reveals new insights on the effects of minimally invasive Sacroiliac joint fusion in managing severe Sacroiliac tain pain.” This highlights their research The pioneering nature and its contribution to medical understanding. The results showed that despite the reduced pain scores in the actual and sham groups, the difference was small, suggesting that the real benefit of surgical procedures for placebo might be small.
Dr. Landers further discussed the implications of their study, emphasizing: “Through these results, we must consider whether a permanent surgical procedure with relevant risks and complications is reasonable, when its actual effectiveness is so moderate and soothing. The agent effect may significantly affect the outcome. “This study is crucial because it increases cumulative evidence that question the actual benefits of certain surgical interventions compared to placebo effects, especially given the high associated with surgical treatment Expectations and complexity. The group stressed the need for dialogue in the medical community, i.e., when its effectiveness is similar to placebo, it is necessary to have risks and complications associated with irreversible surgical procedures.
Journal Reference
Engelke Marie Randers, Paul Gerdhem and colleagues, “The effects of minimally invasive s-bones joint fusion compared to sham surgery: a double-blind randomized placebo control trial,” eclinicalmedicine, 2024, 2024. /J.eclinm.2024.102438
About the Author
Engelke Marie Randers He graduated from the University of Oslo in 2009 with a PhD dissertation on sacroiliac joint surgery treatment. She is a consultant for spinal deformity in the orthopedic surgery department of the University Hospital of Oslo, Norway.
Paul Gerdhem Graduated from the Karolinska Institutet, Sweden in 1993, he served as a doctorate in medicine, received his PhD from Lund University in Sweden in 2004 and became an associate professor in 2005. From 2019 to 2022, he served as an adjunct professor at the Karolinska Institutet. Since 2023, he is a complete professor of orthopedics at Uppsala University in Sweden.
Britt Stuge He has been a physical therapist since 1982, received his PhD from the University of Oslo in 2005 and is a pioneer and well-known researcher in the field of pelvic belt pain. She is currently a senior researcher at the University Hospital of Oslo.
Elias DiarbakerliDr. is a clinical and research physical therapist who specializes in spinal diseases. He is currently a senior fellow at the Karolinska Institutet and a spinal consultant at the Karolinska University Hospital in Sweden.
Lars Nordsletten He began his degree in experimental research in 1994. His main topic is comprehensive alternatives and osteoarthritis and is a professor at the University of Oslo. He is the head of the clinic’s R&D and a consultant surgeon at the University Hospital of Oslo.
Stephen Maximilian Herbert Roll In 1996, Ludwig Maximillian University in Munich, Germany received a doctorate in biomechanical research to conduct orthopedic research at the University of Oslo Hospital and has served as professor at the University of Oslo since 2023.
Thomas Johan Kibsgård He completed his PhD dissertation on Sacroiliac joint fusion and biomechanics at the University of Oslo in 2014, and since 2016 he has served as an associate professor in the study of Sacroiliac joint fusion and spinal deformities. He is also a consultant for spinal deformity in the orthopedic surgery department of the University of Oslo Hospital.
